Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Lymphopenia | 20% - 72% | 7% - 53% | x | x |
Leukopenia | 3% - 35% | 1% - 10% | x | x |
Nausea | 2% - 36% | 2% - 35% | x | x |
Diarrhoea | 2% - 25% | 2% - 15% | x | x |
Vomiting | 2% - 19% | 2% - 14% | x | x |
Neutropenia | 2% - 18% | 1% - 5% | x | x |
Oedema peripheral | 2% - 13% | 1% - 10% | x | |
Anaemia | 2% - 93% | 6% - 88% | x | |
Thrombocytopenia | 2% - 31% | 1% - 22% | x | x |
Renal failure | 1% - 3% | 1% | x | |
Pancytopenia | 1% - 2% | 0% | x | x |
Neoplasm malignant | x | x | ||
Dehydration | x | |||
Oedema | x | |||
Gastrointestinal disorder | x | x | ||
Leukaemia | x | |||
Myelodysplastic syndrome | x | |||
Osteosarcoma | x | |||
Pain | x | x | ||
Swelling | x | |||
Erythema | x | x | ||
Urinary tract disorder | x | |||
Injection site reaction | x | x | ||
Bone cancer metastatic | x | |||
Hypovolaemia | x | |||
Blood and lymphatic system disorders | x | x | ||
Metastatic neoplasm | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |